| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.37M | 32.47M | 13.41M | -3.17M | 35.09M | 49.68M |
| Gross Profit | 27.79M | 31.48M | 11.53M | -4.73M | 34.41M | 48.80M |
| EBITDA | 26.47M | 30.77M | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 24.72M | 30.10M | 10.38M | -4.37M | 33.94M | 48.07M |
Balance Sheet | ||||||
| Total Assets | 299.14M | 310.78M | 391.11M | 237.04M | 246.51M | 223.80M |
| Cash, Cash Equivalents and Short-Term Investments | 433.00K | 1.47M | 6.38M | 1.57M | 865.00K | 825.00K |
| Total Debt | 14.91M | 15.14M | 15.45M | 15.79M | 15.00M | 14.59M |
| Total Liabilities | 15.59M | 16.23M | 76.76M | 17.81M | 16.86M | 16.12M |
| Stockholders Equity | 283.55M | 294.55M | 314.35M | 219.24M | 229.66M | 207.68M |
Cash Flow | ||||||
| Free Cash Flow | 24.64M | 47.57M | 31.10M | 7.16M | 12.49M | 16.99M |
| Operating Cash Flow | 24.64M | 47.57M | 31.10M | 7.16M | 12.49M | 16.99M |
| Investing Cash Flow | 29.91M | 0.00 | 0.00 | 1.40M | 6.44M | 8.72M |
| Financing Cash Flow | -37.23M | -52.48M | -26.30M | -6.46M | -12.45M | -21.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ― | 13.32 | 9.89% | 3.91% | 45.25% | 11.78% | |
76 Outperform | £195.09M | 4.34 | 12.32% | 8.15% | 1.29% | 11.17% | |
76 Outperform | £605.13M | 5.68 | 30.00% | 8.73% | 7.71% | -7.39% | |
76 Outperform | £1.76B | ― | 2.24% | 2.40% | 64.34% | 77.61% | |
74 Outperform | £803.33M | 8.25 | 11.49% | 2.70% | -4.38% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | £827.52M | -13.06 | 5.07% | 2.47% | 66.53% | 100.92% |